BioSAXS-an emerging method to accelerate, enrich and de-risk antimicrobial drug development

• Главные авторы: Christoph Rumancev (Автор), Axel Rosenhahn (Автор), Kai Hilpert (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Antimicrobial resistance is a worldwide threat to modern health care. Low-profit margin and high risk of cross-resistance resulted in a loss of interest in big pharma, contributing to the increasing threat. Strategies to address the problem are starting to emerge. Novel antimicrobial compounds with...